An allele is one of two or more alternative forms of a gene occupying the same chromosomal locus, inherited one from each parent (maternal and paternal), which may produce different phenotypes depending on whether they are dominant, recessive, or demonstrate parent-of-origin effects through genomic imprinting. In diploid organisms, individuals carry two alleles per gene—one from each parent—which may have identical sequences (homozygous) or different sequences (heterozygous), and their expression is determined by dominance relationships, epigenetic modifications, and environmental context.
Think of a recipe for making bread, where you inherit two versions of the same recipe—one from your mother's cookbook, one from your father's. Both recipes are for bread, both occupy the same page number in the family cookbook (same chromosomal locus), but they might have slightly different instructions. Maybe your mother's recipe says "add 2 cups of flour" (one allele), while your father's says "add 3 cups of flour" (different allele). Sometimes one recipe dominates—you always follow dad's "3 cups" instruction even though mom's recipe is still sitting there on the page (dominant allele). Sometimes you blend them (incomplete dominance). But here's where it gets interesting: with genomic imprinting, it's like someone has written "IGNORE THIS RECIPE" across one parent's version in permanent marker (methylation silencing). For the growth hormone gene, the father's recipe might say "make growth hormone" (promote growth), while the mother's recipe says "make growth hormone inhibitor" (restrain growth), and which one gets followed depends on which parent it came from—not on which is "stronger." This is why two parents can pass down the exact same chromosomal deletion, but if it's the father's deletion (Prader-Willi syndrome) versus the mother's deletion (Angelman syndrome), you get completely different diseases—same missing recipes, different marked-up cookbooks.
At fertilization, the zygote receives one allele from the maternal egg and one allele from the paternal sperm → both alleles occupy the same chromosomal position (locus) on homologous chromosomes → DNA sequence may be identical (homozygous: A/A or a/a) or different (heterozygous: A/a). Expression depends on multiple layers:
Standard Mendelian Dominance:
- Dominant allele (A) produces functional protein → masks recessive allele (a) in heterozygote (A/a phenotype = A/A phenotype)
- Recessive allele only expresses when homozygous (a/a)
- Incomplete dominance: both alleles contribute (e.g., pink flowers from red/white parents)
- Codominance: both alleles fully expressed (e.g., AB blood type)
Genomic Imprinting Mechanism:
- During gametogenesis, DNA methyltransferases (DNMT1, DNMT3A, DNMT3B) add CH3 groups (from SAMe) to CpG islands in imprinting control regions
- Methylation silences one parental allele → only unmethylated allele transcribes
- Parent-of-origin marking persists through development → creates monoallelic expression
Growth Hormone Example (Classic Imprinting):
- Paternal allele (unmethylated) → transcription factor binding → somatotropin (GH) gene expression → growth promotion
- Maternal allele (methylated) → silencing of GH gene, activation of somatostatin (GHIH) gene → growth inhibition
- Net growth = paternal drive - maternal restraint
Polymorphism Creation:
- Single nucleotide polymorphisms (SNPs) create allelic variants → ~15 million SNPs differ between any two human genomes
- Example: MTHFR C677T polymorphism: C→T substitution at nucleotide 677 → alanine→valine at position 222 → reduced enzyme thermostability → impaired folate metabolism → decreased 5-MTHF and SAMe → reduced DNA methylation capacity
graph TD
A["Conception: Maternal + Paternal Alleles"] --> B{Same Sequence?}
B -->|Yes| C["Homozygous: A/A or a/a"]
B -->|No| D["Heterozygous: A/a"]
C --> E{Imprinted?}
D --> E
E -->|No| F[Standard Dominance Rules]
E -->|Yes| G[Genomic Imprinting]
F --> H[Dominant Masks Recessive]
F --> I[Codominant Expression]
F --> J[Incomplete Dominance]
G --> K[DNA Methylation Marks CpG Islands]
K --> L[One Parental Allele Silenced]
L --> M[Only Other Allele Expresses]
M --> N[Parent-of-Origin Effect]
N --> O["Example: GH Gene"]
O --> P["Paternal: Somatotropin Growth"]
O --> Q["Maternal: Somatostatin Inhibition"]
H --> R[Phenotype Determination]
I --> R
J --> R
P --> R
Q --> R
Clinical Polymorphism Examples:
COMT Val158Met (rs4680):
- Val/Val (G/G): high enzyme activity → rapid dopamine clearance → stress resilience, lower pain sensitivity
- Met/Met (A/A): low enzyme activity → slow dopamine clearance → anxiety vulnerability, higher pain sensitivity, better cognition
- Val/Met (G/A): intermediate phenotype
VDR polymorphisms (BsmI, FokI, TaqI):
- Affect vitamin D receptor function → alter calcium absorption, immune regulation, bone density
- FokI ff genotype: longer, less active VDR protein → lower BMD, higher autoimmune risk
HLA alleles (chromosome 6p21):
- Extreme polymorphism (>10,000 alleles across HLA-A, -B, -C, -DR, -DQ, -DP)
- Each allele presents different peptide repertoire to T cells
- HLA-B27: 90-fold increased risk of ankylosing spondylitis
- HLA-DQ2/DQ8: necessary (not sufficient) for celiac disease
Personalized Medicine in cPNI:
Allelic variation is the molecular foundation for why identical interventions produce different outcomes in different patients. A practitioner must consider genotype-environment interactions:
Methylation and Stress Resilience:
- MTHFR C677T homozygotes (T/T): ~70% reduced enzyme activity → require higher folate intake (800-1000 μg vs 400 μg RDA), methylated B vitamins (5-MTHF, methylcobalamin), and betaine supplementation to maintain SAMe pools for DNA methylation
- Connects to Metamodel 1 (genetics-environment interaction) and epigenetics—patients with MTHFR variants show greater epigenetic instability under stress
Neurotransmitter Metabolism:
- COMT Met/Met individuals: require lower-stress environments (stress amplifies already-high prefrontal dopamine → anxiety, rumination), benefit from magnesium and SAMe to support methylation-based detoxification
- COMT Val/Val individuals: tolerate higher stress loads, may need dopamine support (L-tyrosine, Mucuna pruriens) for motivation
Immune-Endocrine Crosstalk:
- HLA typing predicts autoimmune risk and guides dietary interventions (HLA-DQ2/DQ8 carriers must strictly avoid gliadin even if serology negative)
- VDR polymorphisms guide vitamin D dosing: FokI FF genotype may need 4000-6000 IU/day vs 2000 IU for ff genotype to achieve 25(OH)D >40 ng/mL
Parent-of-Origin Effects and Metabolic Programming:
- Maternal imprinting drives metabolic constraint (somatostatin, growth inhibition), while paternal imprinting drives resource acquisition (somatotropin, growth promotion)
- Explains why maternal stress/malnutrition during pregnancy affects offspring metabolism more profoundly than paternal factors—maternal alleles impose metabolic "brakes"
- Connects to metabolic programming and intrauterine programming
Pharmacogenetics:
- CYP450 alleles determine drug metabolism: CYP2D6 poor metabolizers (5-10% Caucasians) cannot activate codeine → no analgesia, but ultra-rapid metabolizers (up to 30% North Africans) risk overdose
- Affects NSAID metabolism, hormone clearance, detoxification capacity
Evolutionary Medicine Context:
- heterozygote advantage: sickle cell trait (HbA/HbS) confers malaria resistance without sickle cell disease—demonstrates why harmful alleles persist in populations
- founder effects: isolated populations (Ashkenazi Jews, Finns) show high frequencies of disease alleles due to genetic drift, not selection
- Chuvash Polycythemia: VHL mutation endemic in Chuvash population → chronic HIF activation → adaptive in hypoxic mountain environments, maladaptive at sea level
Threshold for Genetic Testing:
Consider testing when:
- Treatment resistance despite appropriate intervention
- Strong family history of specific conditions
- Unexplained symptoms with high stress sensitivity
- Planning methylation support protocols
- Assessing autoimmune risk (HLA typing)
- Diploid organisms carry two alleles per gene—one inherited from each parent
- ~15 million single nucleotide polymorphisms (SNPs) differentiate any two human genomes, creating allelic diversity
- Dominant alleles require only one copy to manifest phenotype; recessive alleles require two copies (homozygosity)
- Genomic imprinting affects ~150-200 human genes, silencing one parental allele via DNA methylation at CpG islands
- MTHFR C677T T/T genotype occurs in ~10-15% of Caucasians, ~25% of Hispanics, ~5% of Africans—reduces enzyme activity by 70%
- COMT Val158Met polymorphism: Val/Val has 3-4 times higher enzyme activity than Met/Met
- HLA genes are the most polymorphic in the human genome—over 10,000 alleles across all HLA loci
- HLA-B27 present in 8% of Caucasians, but 90% of ankylosing spondylitis patients
- Prader-Willi syndrome (paternal chr15q deletion) and Angelman syndrome (maternal chr15q deletion) demonstrate identical genetic lesions producing opposite phenotypes due to imprinting
- Allele frequencies change through natural selection, genetic drift, founder effects, and mutation—evolution acts on allelic variation
- heterozygote advantage maintains polymorphism: heterozygotes have higher fitness than either homozygote (e.g., sickle cell trait)
- penetrance varies: not all individuals with disease-associated alleles develop disease (BRCA1 mutation = 70% breast cancer risk, not 100%)
- genomic-imprinting — epigenetic silencing of one parental allele through methylation creates parent-of-origin effects where phenotype depends on which parent transmitted the allele
- DNA methylation — DNMT enzymes add CH3 groups to CpG islands to silence imprinted alleles and regulate gene expression
- parent-of-origin-effects — maternal and paternal alleles produce different phenotypes due to differential methylation marking during gametogenesis
- somatotropin — growth hormone gene shows paternal allele expression promoting anabolic growth
- somatostatin — growth hormone inhibitor gene shows maternal allele expression restraining growth
- SAMe — S-adenosylmethionine donates methyl groups for DNA methylation that silences imprinted alleles
- DNA methyltransferases — DNMT1, DNMT3A, DNMT3B add methyl marks to establish and maintain genomic imprinting
- SNP — single nucleotide polymorphisms create allelic variants affecting enzyme activity, receptor binding, and disease risk
- MTHFR — C677T polymorphism creates allele with reduced enzyme activity affecting folate metabolism and methylation capacity
- COMT — Val158Met polymorphism creates alleles with 3-4 fold different catechol-O-methyltransferase activity affecting dopamine clearance and stress response
- VDR — vitamin D receptor polymorphisms (BsmI, FokI, TaqI) create alleles affecting calcium metabolism, immune function, and bone density
- HLA — human leukocyte antigen alleles determine antigen presentation repertoire and autoimmune disease susceptibility
- epigenetics — allele expression modified by methylation, acetylation, and chromatin remodeling without changing DNA sequence
- CYP450 — cytochrome P450 enzyme alleles determine drug metabolism capacity affecting pharmacological responses
- 5-MTHF — 5-methyltetrahydrofolate production reduced in MTHFR C677T T/T carriers requiring supplementation
- methylcobalamin — active B12 form needed to regenerate methionine from homocysteine, supporting SAMe production for methylation
- heterozygote advantage — having two different alleles confers survival benefit over either homozygote (sickle cell trait protects against malaria)
- natural selection — differential survival of alleles drives evolutionary adaptation by changing allele frequencies across generations
- founder effects — small founding populations amplify certain alleles randomly creating geographic variation in allele frequencies
- genetic drift — random changes in allele frequencies in populations due to chance events independent of selection
- Prader-Willi syndrome — loss of paternal alleles on chr15q11-13 causes hyperphagia, obesity, intellectual disability due to loss of paternally-expressed genes
- Angelman syndrome — loss of maternal alleles on chr15q11-13 causes severe intellectual disability, ataxia, happy demeanor due to loss of maternally-expressed UBE3A
- metabolic programming — maternal alleles impose metabolic constraints through imprinted genes affecting offspring metabolism lifelong
- intrauterine programming — maternal nutrition and stress during pregnancy affect offspring through epigenetic modification of fetal alleles
- pharmacogenetics — allelic variants in drug-metabolizing enzymes determine therapeutic response and adverse reaction risk
- penetrance — proportion of individuals carrying disease allele who develop phenotype varies by genetic background and environment
- Chuvash Polycythemia — VHL R200W allele common in Chuvash population creates constitutive HIF activation adaptive at altitude
- celiac disease — HLA-DQ2 or HLA-DQ8 alleles necessary but not sufficient for gluten-triggered autoimmunity
- ankylosing spondylitis — HLA-B27 allele increases risk 90-fold through molecular mimicry and misfolding mechanisms
- gliadin — wheat protein triggers immune response specifically in HLA-DQ2/DQ8 carriers through specific peptide presentation